| Home | E-Submission | Sitemap | Contact Us |  
top_img
Cancer Research and Treatment > Epub ahead of print
doi: https://doi.org/10.4143/crt.2024.003    [Epub ahead of print]
Development and Feasibility Evaluation of Smart Cancer Care 2.0 Based on Patient-Reported Outcomes for Post-discharge Management of Patients with Cancer
Jin Ah Kwon1 , Songsoo Yang1, Su-Jin Koh2, Young Ju Noh3, Dong Yoon Kang4,5, Sol Bin Yang4, Eun Ji Kwon4, Jeong-Wook Seo6, Jin sung Kim1 , Minsu Ock4,5
1Department of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
2Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
3Department of Radiation Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
4Department of Preventive Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
5Department of Preventive Medicine, Brain Korea 21 Project, University of Ulsan College of Medicine, Seoul, Korea
6Public Health and Medical Services Team, Ulsan University Hospital, Ulsan, Korea
Correspondence  Jin sung Kim ,Tel: 82-52-250-7109, Fax: 82-52-250-7289, Email: admetus07@uuh.ulsan.kr
Minsu Ock ,Tel: 82-52-250-8793, Fax: 82-52-250-7289, Email: ohohoms@naver.com
Received: January 2, 2024;  Accepted: April 7, 2024.  Published online: April 9, 2024.
ABSTRACT
Purpose
A “Smart Cancer Care” platform that integrates patient-reported outcomes (PROs) with management has been established in Korea. This study focused on improving health behaviors and connecting patients to welfare services by introducing and assessing the feasibility of “Smart Cancer Care 2.0,” an enhanced version designed for monitoring complications post-cancer treatment.
Materials and Methods
Smart Cancer Care 2.0 was developed by conducting a literature review and consulting with expert panels to identify symptoms or variables requiring monitoring and management guidelines based on the treatment type. Qualitative and quantitative surveys were conducted to assess the feasibility of the app and web system based on the experiences of patients with cancer and healthcare workers.
Results
A total of 81 symptoms or variables (chemotherapy-, surgery-, radiotherapy-, rehabilitation-, and health management-related) were selected for management in Smart Cancer Care 2.0. PROs for these symptoms were basically categorized into three severity grades: preventive management, self-treatment, and consultation with a healthcare worker or visit to a healthcare institution. The overall mean scores in the feasibility evaluation by patients and healthcare workers were 3.83 and 3.90 points, respectively, indicating high usefulness.
Conclusion
Smart Cancer Care 2.0 leverages the existing information and communication technologies–based platform, Smart Cancer Care, and further includes health behaviors and welfare services. Smart Cancer Care 2.0 may play a crucial role in establishing a comprehensive post-discharge management system for patients with cancer as it provides suitable interventions based on patients’ responses and allows the regularly collected PROs to be easily viewed for streamlined care.
Key words: Mobile applications, Patient reported outcome measures, Drug-related side effects and adverse reactions, Patient discharge
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI